FEE
Intelligence feed
Full press — raw attributed stream including general news
Sources healthyNewest data 54m ago
ON TAPE
30
30 company-linked
FILINGS
30
events · official
INSIDERS
0
PDMR prints
PRESS
0
company-linked news
30 press items · newest first
ATTRIBUTED · DAY-GROUPED
THU 4 JUN13
WED 3 JUN10
TUE 2 JUN7
- otherOFFICIALIssuer IR via MFN (press rooms)
AstraZeneca: Camizestrant combination delayed time to first progression by 55% and to second progression by 37% in patients with advanced HR-positive breast cancer with an emergent ESR1 mutation in SERENA-6 trial